[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337675-105":59,"doc-detail-337675-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","clustering-of-hr-her2-breast-cancer-in-an-asian-cohort-is-driven-by-immune-phenotypes","Clustering of HR +/HER2 − breast cancer in an Asian cohort is driven by immune phenotypes","","Breast cancer shows substantial heterogeneity across clinically actionable subtypes. This study examines whether distinct Asian breast cancer subtypes exist by analyzing transcriptomic profiles from 934 patients in a Malaysian cohort. Results indicate HR +/HER2− samples cluster according to immune phenotypes, diverging from the luminal A–luminal B framework previously observed in European ancestry cohorts. Higher immune-score clusters associate with lower tumor mutational burden, reduced homologous recombination deficiency, and fewer copy number aberrations, supporting non-canonical tumor–immune pathways and motivating immunotherapy tailored to this population.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clustering-of-hr-her2-breast-cancer-in-an-asian-cohort-is-driven-by-immune-phenotypes/337675/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clustering-of-hr-her2-breast-cancer-in-an-asian-cohort-is-driven-by-immune-phenotypes/337675.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the study’s main goal for Asian breast cancer subtypes?","Question",{"text":113,"@type":114},"To determine whether distinct breast cancer subtypes exist in the Asian population by analyzing transcriptomic profiles from a Malaysian cohort.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do HR+/HER2− samples cluster in this research?",{"text":118,"@type":114},"They form a distinct clustering pattern driven by immune phenotypes rather than following the conventional luminal A–luminal B paradigm.",{"name":120,"@type":111,"acceptedAnswer":121},"What genomic characteristics relate to higher immune scores in the HR+/HER2− cluster?",{"text":122,"@type":114},"Higher immune-score clusters show lower tumor mutational burden, lower homologous recombination deficiency scores, and fewer copy number aberrations.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337675,1790146088,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Pan etal. Breast Cancer Research (2024) 26:67 [https://doi.org/10.1186/s13058-024-01826-5](https://doi.org/10.1186/s13058-024-01826-5)  \nBreast Cancer Research  \n RESEARCH Open Access  \nClustering of HR +/HER2 − breast cancer in an Asian cohort is driven by immune phenotypes  \nJia‑Wern Pan 1*, Mohana Ragu1, Wei‑Qin Chan 1, Siti Norhidayu Hasan1, Tania Islam2, Li‑Ying Teoh2, Suniza Jamaris2, Mee‑Hoong See2, Cheng‑Har Yip3, Pathmanathan Rajadurai3,4, Lai‑Meng Looi5, Nur Aishah MohdTaib2, Oscar M. Rueda6, Carlos Caldas7,8, Suet‑Feung Chin7, Joanna Lim 1 and Soo‑Hwang Teo1,9  \nAbstract  \nBreast cancer exhibits significant heterogeneity, manifesting in various subtypes that are critical in guiding treatment decisions. This study aimed to investigate the existence of distinct subtypes of breast cancer within the Asian popu‑ lation, by analysing the transcriptomic profiles of 934 breast cancer patients from a Malaysian cohort. Our findings reveal that the HR + /HER2− breast cancer samples display a distinct clustering pattern based on immune phenotypes, rather than conforming to the conventional luminal A‑luminal B paradigm previously reported in breast cancers from women of European descent. This suggests that the activation of the immune system may play a more impor‑ tant role in Asian HR + /HER2− breast cancer than has been previously recognized. Analysis of somatic mutations by whole exome sequencing showed that counter‑intuitively, the cluster of HR + /HER2− samples exhibiting higher immune scores was associated with lower tumour mutational burden, lower homologous recombination deficiency scores, and fewer copy number aberrations, implicating the involvement of non‑canonical tumour immune pathways. Further investigations are warranted to determine the underlying mechanisms of these pathways, with the potential to develop innovative immunotherapeutic approaches tailored to this specific patient population.  \n*Correspondence:  \nJia‑Wern Pan  \n[jiawern.pan@cancerresearch. my](jiawern.pan@cancerresearch. my)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativecom](http://creativecom)‑ [mons.org/publicdomain/zero/1.0/](mons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nPan etal. Breast Cancer Research (2024) 26:67  \nIntroduction  \nBreast cancer is a highly heterogeneous disease, characterized by diverse subtypes that have important implications in guiding treatment [1–4]. These distinct subtypes encompass variations in clinical presentation, molecular profiles, and response to treatment, highlighting the complex nature of breast cancer. The classification of breast cancer subtypes has provided valuable insights into disease prognosis and treatment selection, enabling more personalized and targe","cbCairHOM5LW4R92","https://ap.wps.com/l/cbCairHOM5LW4R92","pdf",1675666,14,"English","# Abstract\n# Introduction","[{\"question\":\"What is the study’s main goal for Asian breast cancer subtypes?\",\"answer\":\"To determine whether distinct breast cancer subtypes exist in the Asian population by analyzing transcriptomic profiles from a Malaysian cohort.\"},{\"question\":\"How do HR+/HER2− samples cluster in this research?\",\"answer\":\"They form a distinct clustering pattern driven by immune phenotypes rather than following the conventional luminal A–luminal B paradigm.\"},{\"question\":\"What genomic characteristics relate to higher immune scores in the HR+/HER2− cluster?\",\"answer\":\"Higher immune-score clusters show lower tumor mutational burden, lower homologous recombination deficiency scores, and fewer copy number aberrations.\"}]","Clustering of HR +/HER2 − breast cancer in an Asian cohort is driven by immune phenotypes | PDF",1790020085,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5dd228ddc08d66922d26e632237fac3c.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18cb216eec13831f5dc85bec81e4331c.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7269f5411cb75883f4109d2e6902dc2.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f998928ad0a6339bc4c2dbae325183dd.webp",980,1301]